Your browser doesn't support javascript.
loading
Evaluation of Pathway to Diagnosis of Pediatric Brain Tumors in Tamil Nadu, India.
Kartik, Prerna; Liu, Jo-Fen; Sudarsan, Rishan Thimma; Srinivasan, Aarthi; Jayaraman, Dhaarani; Sivaprakasam, Ponni; John, Rikki; Uppuluri, Ramya; Scott, Julius Xavier; Jalali, Rakesh; Dandapani, Madhumita.
Afiliación
  • Kartik P; School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Liu JF; Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Sudarsan RT; Apollo Proton Cancer Centre, Chennai, India.
  • Srinivasan A; Kanchi Kamakoti Childs Trust Hospital, Chennai, India.
  • Jayaraman D; Sri Ramachandra Institute for Higher Education and Research, Chennai, India.
  • Sivaprakasam P; Gleneagles Global Hospital, Chennai, India.
  • John R; Christian Medical College, Vellore, India.
  • Uppuluri R; Apollo Proton Cancer Centre, Chennai, India.
  • Scott JX; Sri Ramachandra Institute for Higher Education and Research, Chennai, India.
  • Jalali R; Kanchi Kamakoti Childs Trust Hospital, Chennai, India.
  • Dandapani M; Children's Brain Tumour Research Centre, University of Nottingham, Nottingham, United Kingdom.
JCO Glob Oncol ; 10: e2300214, 2024 Feb.
Article en En | MEDLINE | ID: mdl-38386953
ABSTRACT

PURPOSE:

Delayed diagnosis and poor awareness are significant barriers to the early intervention of pediatric brain tumors. This multicenter observational study aimed to evaluate the baseline routes and time to diagnosis for pediatric brain tumors in Tamil Nadu (TN), with the goal of promoting early diagnosis and timely referrals in the future.

METHODS:

A standard proforma was used to retrospectively collect information on demographics, diagnosis, referral pathways, and symptoms of incident pediatric brain tumor cases between January 2018 and October 2020 across eight tertiary hospitals in TN. Dates of symptom onset, first presentation of health care, and diagnosis were used to calculate total diagnostic interval (TDI), patient interval (PI), and diagnostic interval (DI).

RESULTS:

A total of 144 cases (mean age, 6.64 years; range, 0-15.1 years) were included in the analysis. Among those, 94% (135/144) were from city/district areas, 40% (55/144) were self-referred, and 90% (129/144) had one to three health care professional visits before diagnosis. Median TDI, PI, and DI were 3.5 (IQR, 1-9.3), 0.6 (IQR, 0.1-4.6), and 0.6 (IQR, 0-3.3) weeks, respectively. Low-grade gliomas had the longest median TDI (6.6 weeks), followed by medulloblastomas (4.6 weeks) and high-grade gliomas (3.3 weeks). Average number of symptoms recorded was 1.7 at symptom onset and 1.9 at diagnosis.

CONCLUSION:

Although there are some similarities with data from the United Kingdom, many low-grade and optic pathway tumors were unaccounted for in our study. DIs were relatively short, which suggests that infrastructure may not be a problem in this cohort. Increased training and establishment of proper cancer registries, combined with proper referral pathways, could enhance early diagnosis for these children.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioma Límite: Adolescent / Child / Child, preschool / Humans / Infant / Newborn País/Región como asunto: Asia Idioma: En Revista: JCO Glob Oncol / JCO global oncology Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioma Límite: Adolescent / Child / Child, preschool / Humans / Infant / Newborn País/Región como asunto: Asia Idioma: En Revista: JCO Glob Oncol / JCO global oncology Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos